
Archive for the ‘All Recent Posts’ Category
VIDEO – Valeo Pharma $VPH $VPHIF Hesperco Capsules at Core of Montreal Heart Institute’s Coronavirus Clinical Trial $HLS.ca $MDP.ca $GUD.ca $RX.ca

VIDEO – ORTHO Regenerative Technologies $ORTH.ca $ORTIF is Using Proprietary Tech to Improve Surgery Success Rates and Seize a $5bn Market Opportunity

ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
- In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.
- This includes Wound Healing, Cartilage repair and Osteo-arthritis
So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:
Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):
- 4m patients in the U.S. alone
- 600,000 annual surgeries in the U.S. alone
- $600m+ market opportunity
Meniscus Tear Repair (which is painful and compromises knee function):
- There are 1.2m surgeries annually in U.S. alone
- $1bn+ market opportunity
Cartilage Lesions Repair (this is where lesions cause friction and pain):
- 1.2m detected lesions annually in U.S. alone
- 120,000 surgeries and a lack of options
- $1bn+ market opportunity
Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.
@Novamind_Inc $NM.ca $NVMDF Weekly Roundup $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca



A weekly summary of Novamind news and media


FEATURES February 19, 2021
Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering
Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.
FEATURES February 18, 2021
Novamind Leading the Charge to Deliver Mental Health Alternatives
Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.


Novamind Announces Symbol Change on OTC Market To “NVMDF”
February 19, 2021


Follow @novamind_inc on Instagram



Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca
VIDEO – Universal PropTech $UPI Secures Investment and Rights To Finger Scan Test Designed To Detect COVID-19 In Less Than A Minute $AAT.ca $LPS.ca $EGT.ca

As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada.
More than just lip service, UPI clients include:
· Federal Government facilities for over 40 years
· Manulife
· Brookfield
· Billy Bishop Airport
· University of Toronto
· …. and many more
As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with. But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues … and he has delivered pretty strongly against this mission statement in 2021.
BUT TODAY HE TOOK A GIANT LEAP FORWARD
The press release headline says it all:
Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute
In short, this technology takes a non-invasive scan of a person’s finger with a harmless beam of light designed to provide confirmation of Covid-19 infection in less than 1 minute.
How significant is this announcement and what does it mean to the Company’s growth?
Watch our interview with CGO Carnevale to learn all about it.
Harborside Inc. $HBOR $HBORF Announces Closing of Upsized Private Placement For Gross Proceeds of C$35,103,045 $VFF.ca $HARV.ca $ACB.ca

Harborside Inc. (“Harborside”, or the “Company) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, is pleased to announce that it has closed its previously announced upsized brokered private placement of units of the Company at a price of C$2.55 per SVS Unit (as defined below) and C$255.00 per MVS Unit (as defined below) for aggregate gross proceeds of C$35,103,045 (the “Offering”). Beacon Securities Limited and ATB Capital Markets acted as co-lead agents in connection with the Offering (the “Agents”).
“We are very pleased with the strong investor interest and demand we received during our recent upsized offering,” said Peter Bilodeau, Interim CEO of Harborside. “With a strengthened balance sheet, Harborside is well positioned to further accelerate our growth as we enter 2021. We remain focused on continuing to build scale in the California market by optimizing and generating further efficiencies at our Salinas farm while continuing to provide best-in-class retail experiences and the high-quality cannabis products our customers in California have come to expect from Harborside.”
Each unit issued to non-residents of the United States (an “SVS Unit”) is comprised of one subordinate voting share of the Company (a “Subordinate Voting Share”) and one Subordinate Voting Share purchase warrant (a “Warrant”) of the Company. Each Warrant underlying an SVS Unit is exercisable to acquire one Subordinate Voting Share of the Company for a period of 36 months following closing of the Offering (the “Closing”) at an exercise price of C$3.69 per Subordinate Voting Share, subject to adjustment and acceleration in certain events. A total of 5,806,700 SVS Units were issued pursuant to the Offering.
All investors that are considered residents of the United States under the United States Securities Exchange Act of 1934 were issued units (each, an “MVS Unit”) comprised of multiple voting shares of the Company (the “Multiple Voting Shares”) and Multiple Voting Share purchase warrants of the Company, based on the same economic equivalency of each Multiple Voting Share converting into 100 Subordinate Voting Shares. The Multiple Voting Shares are intended to minimize the proportion of the outstanding voting securities of the Company that are held by residents of the United States for purposes of determining whether the Company is a “foreign private issuer”. The holders of Multiple Voting Shares are entitled to one vote in respect of each Subordinate Voting Share into which such Multiple Voting Share could be converted, and as such the Multiple Voting Shares do not necessarily hold voting rights that are superior to the holders of Subordinate Voting Shares, on an as converted to Subordinate Voting Shares basis. A total of 79,592 MVS Units were issued pursuant to the Offering.
In consideration for their services, the Company paid the Agents a cash commission equal to C$1,451,340.75 and issued the Agents an aggregate of 569,154 broker warrants (“Broker Warrants”). Each Broker Warrant is exercisable to acquire, within 12 months from Closing, one SVS Unit at an exercise price of C$2.55 per SVS Unit.
VIDEO – $KABN.ca North America Discusses Launch of Liquid Avatar App in the #Apple Store and #Google Play $MOS.ca $MOGO.ca $CTZ.ca

VIDEO – Novamind $NM.ca Is Building the Infrastructure Required for a Regulated Psychedelics Industry $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

The global behavioural health market size is expected to reach approximately US$ 245 billion by 2027 and estimated to grow at CAGR of 2.5 % over the forecast time frame 2020 to 2027.
As a consequence of the increasing incidence of mental health disorders, global demand for mental health facilities is increasing.
Psychedelics are going to go through parabolic, paradigm-shifting growth because of their ability to treat anxiety and depression amongst other things
Novamind is a leading mental health company specialized in psychedelic medicine, building the infrastructure required for a regulated psychedelics industry.
Highlights:
- Rapidly expanding a network of outpatient mental health clinics and research sites
- 4 clinics in Utah, 1 more anticipated this quarter
- Provides ketamine-assisted psychotherapy and Spravato™ (esketamine) treatments;
- Ketamine treatment volume grew 90% from 2019 to 2020
- During the same period, total Spravato™ treatments rose 400%
- Positioned to facilitate MDMA and psilocybin therapy post-FDA approval
- Building centers of excellence for future approved psychedelic treatments
- Approximately CAN$1,900,000 in 2019 revenue
- Strong insider ownership (32.3%)

Watch this powerful interview with Dr. Reid Robison, Chief Medical Officer and Director of Novamind.
Industry Bulletin: Osisko Mining Increase High-Grade Gold Resources at Windfall SPONSOR: Durango Resources $DGO.ca $OSK.ca $BTR.ca

- Indicated and Inferred Categories Amounted to 6 Million Ounces
- Windfall Among The Best High-Grade Development Projects Globally
- Durango Waits On Their First Assays Bordering Windfall
- Trove and East Barry Drill Projects
- 20 High Priority Targets
- 40% Inside Ownership
Osisko Mining (OSK:TSX) today provided an updated mineral resource estimate for its 100% owned Windfall gold deposit, located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Québec.
The company said that highlights of an updated resource estimate include measured and indicated gold ounces increase by 54% and a grade of 9.6 g/t Au, which continues to increase with infill program. The total gold resources in measured, indicated and inferred categories amounted to 6 million ounces.
Osisko added that this mineral resource estimate places Windfall among the best high-grade development projects globally.
The mineral resource defined by Osisko comprises 521,000 tonnes at 11.3 g/t Au (189,000 ounces) in the measured mineral resource category, 5,502,000 tonnes at 9.4 g/t Au (1,668,000 ounces) in the indicated mineral resource category and 16,401,000 tonnes at 8.0 g/t Au (4,244,000 ounces) in the inferred mineral resource category.
Osisko is a mineral exploration company focused on the acquisition, exploration, and development of precious metal resource properties in Canada.





